Related Experiment Video
Updated: Feb 4, 2026

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights
Published on: October 25, 2024
[Falling risk factors in patients with arterial hypertension 55+ years old]
A A Zarudsky1, E P Kulakova2, A E Markovskaya3
1Regional State Budgetary Institution of Health Care "Saint Ioasaph Belgorod Regional Clinical Hospital".
Abstract:
Arterial hypertension (AH) is the most prevalent cardiac risk factor in old patients. Falls-related complications includes increased disability and mortality, decreased activity levels, quality of life, and overall health status. So falls are an important health problem. The aim of our study was to study falls in patients with AH 56+ years old finding fall risk factors in this population.
Methods:
We examined 146 patients. 50 patients with AH had a fall during last 6 month. 96 patients with AH had no falls during this period.
Results:
According to our study major risk factors for fall in population with AH are age, female sex, stratify sore value and blood pressure levels at admission. Patients who had experienced falls during last 6 month had significantly higher systolic, diastolic and pulsed blood pressure at admission without good blood pressure control. All differences in blood pressure were not reproduced in patients at discharge. So we suggest that ambulatory blood pressure control is important for fall prevention in people with AH 55+ years old.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Free-falling Bodies: Example
The...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

